Andrey Meshcheryakov

4PUBLICATIONS
24CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 07, 2021
[Surgical and combined treatment of patients with duodenal stromal tumors].

P P Arkhiri, I S Stilidi, S N Nered

|Sep 18, 2020
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.

Alexander M M Eggermont, Christian U Blank, Mario Mandala

Pageof 1